|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 347 for Nr1h4

Category restricted to Publication (x)

0.06s

Categories

Category: Publication
Type Details Score
Publication  
First Author: Szalowska E
Year: 2015
Journal: BMC Genomics
Title: Cyclosporin A induced toxicity in mouse liver slices is only slightly aggravated by Fxr-deficiency and co-occurs with upregulation of pro-inflammatory genes and downregulation of genes involved in mitochondrial functions.
Volume: 16
Pages: 822
Publication
First Author: Lukovac S
Year: 2009
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.
Volume: 297
Issue: 3
Pages: G520-31
Publication
First Author: van Dijk TH
Year: 2009
Journal: J Biol Chem
Title: An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr-/- mice.
Volume: 284
Issue: 16
Pages: 10315-23
Publication  
First Author: Martinot E
Year: 2017
Journal: Sci Rep
Title: Bile acid homeostasis controls CAR signaling pathways in mouse testis through FXRalpha.
Volume: 7
Pages: 42182
Publication
First Author: Martinot E
Year: 2017
Journal: Stem Cell Reports
Title: The Bile Acid Nuclear Receptor FXRα Is a Critical Regulator of Mouse Germ Cell Fate.
Volume: 9
Issue: 1
Pages: 315-328
Publication
First Author: Bjursell M
Year: 2013
Journal: PLoS One
Title: Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.
Volume: 8
Issue: 5
Pages: e64721
Publication  
First Author: Yang J
Year: 2023
Journal: Int J Mol Sci
Title: Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice.
Volume: 24
Issue: 4
Publication  
First Author: Lin C
Year: 2022
Journal: Biomed Pharmacother
Title: Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse.
Volume: 150
Pages: 112984
Publication
First Author: Huber RM
Year: 2002
Journal: Gene
Title: Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters.
Volume: 290
Issue: 1-2
Pages: 35-43
Publication
First Author: Downes M
Year: 2003
Journal: Mol Cell
Title: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.
Volume: 11
Issue: 4
Pages: 1079-92
Publication
First Author: Wang XX
Year: 2009
Journal: Am J Physiol Renal Physiol
Title: The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.
Volume: 297
Issue: 6
Pages: F1587-96
Publication
First Author: Cho JY
Year: 2010
Journal: J Lipid Res
Title: Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.
Volume: 51
Issue: 5
Pages: 1063-74
Publication
First Author: Lien F
Year: 2014
Journal: J Clin Invest
Title: Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.
Volume: 124
Issue: 3
Pages: 1037-51
Publication
First Author: Kim DH
Year: 2015
Journal: EMBO J
Title: A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.
Volume: 34
Issue: 2
Pages: 184-99
Publication
First Author: Cheng Q
Year: 2015
Journal: Mol Endocrinol
Title: Chronic activation of FXR in transgenic mice caused perinatal toxicity and sensitized mice to cholesterol toxicity.
Volume: 29
Issue: 4
Pages: 571-82
Publication
First Author: Valanejad L
Year: 2017
Journal: PLoS One
Title: Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids.
Volume: 12
Issue: 1
Pages: e0170960
Publication
First Author: Nie H
Year: 2017
Journal: Biochim Biophys Acta
Title: MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Volume: 1863
Issue: 12
Pages: 3087-3094
Publication
First Author: Gao Y
Year: 2018
Journal: Exp Cell Res
Title: Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice.
Volume: 371
Issue: 2
Pages: 301-310
Publication  
First Author: Qiang S
Year: 2020
Journal: Diabetes Res Clin Pract
Title: Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy.
Volume: 161
Pages: 108033
Publication  
First Author: Ma Y
Year: 2021
Journal: Front Cell Dev Biol
Title: Combined Analysis of Expression Profiles in a Mouse Model and Patients Identified BHMT2 as a New Regulator of Lipid Metabolism in Metabolic-Associated Fatty Liver Disease.
Volume: 9
Pages: 741710
Publication
First Author: Xu Y
Year: 2021
Journal: Nat Metab
Title: Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.
Volume: 3
Issue: 1
Pages: 59-74
Publication
First Author: Song X
Year: 2020
Journal: Nature
Title: Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis.
Volume: 577
Issue: 7790
Pages: 410-415
Publication
First Author: Chong HK
Year: 2010
Journal: Nucleic Acids Res
Title: Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.
Volume: 38
Issue: 18
Pages: 6007-17
Publication
First Author: Otte K
Year: 2003
Journal: Mol Cell Biol
Title: Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol.
Volume: 23
Issue: 3
Pages: 864-72
Publication
First Author: Singh AB
Year: 2020
Journal: Physiol Rep
Title: FXR activation promotes intestinal cholesterol excretion and attenuates hyperlipidemia in SR-B1-deficient mice fed a high-fat and high-cholesterol diet.
Volume: 8
Issue: 5
Pages: e14387
Publication
First Author: Ijssennagger N
Year: 2021
Journal: JHEP Rep
Title: Ablation of liver Fxr results in an increased colonic mucus barrier in mice.
Volume: 3
Issue: 5
Pages: 100344
Publication
First Author: Zhang M
Year: 2018
Journal: Dig Liver Dis
Title: FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.
Volume: 50
Issue: 10
Pages: 1068-1075
Publication
First Author: de Boer JF
Year: 2017
Journal: Gastroenterology
Title: Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
Volume: 152
Issue: 5
Pages: 1126-1138.e6
Publication
First Author: Stroeve JH
Year: 2010
Journal: Lab Invest
Title: Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
Volume: 90
Issue: 10
Pages: 1457-67
Publication
First Author: Kok T
Year: 2003
Journal: J Biol Chem
Title: Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
Volume: 278
Issue: 43
Pages: 41930-7
Publication
First Author: Milona A
Year: 2010
Journal: Am J Physiol Gastrointest Liver Physiol
Title: The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr.
Volume: 298
Issue: 2
Pages: G151-8
Publication
First Author: Bellafante E
Year: 2020
Journal: Sci Rep
Title: Maternal glucose homeostasis is impaired in mouse models of gestational cholestasis.
Volume: 10
Issue: 1
Pages: 11523
Publication
First Author: Li L
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
Volume: 441
Issue: 4
Pages: 880-5
Publication
First Author: Chen F
Year: 2003
Journal: J Biol Chem
Title: Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter.
Volume: 278
Issue: 22
Pages: 19909-16
Publication
First Author: Renga B
Year: 2010
Journal: Biochim Biophys Acta
Title: The bile acid sensor FXR regulates insulin transcription and secretion.
Volume: 1802
Issue: 3
Pages: 363-72
Publication
First Author: Ge X
Year: 2011
Journal: J Lipid Res
Title: Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis.
Volume: 52
Issue: 8
Pages: 1561-8
Publication
First Author: Byun S
Year: 2018
Journal: Nat Commun
Title: Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
Volume: 9
Issue: 1
Pages: 2590
Publication
First Author: de Boer JF
Year: 2020
Journal: J Lipid Res
Title: A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice.
Volume: 61
Issue: 3
Pages: 291-305
Publication
First Author: Wang B
Year: 2020
Journal: Exp Cell Res
Title: Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
Volume: 390
Issue: 1
Pages: 111949
Publication
First Author: Li Z
Year: 2019
Journal: J Bone Miner Res
Title: Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice.
Volume: 34
Issue: 4
Pages: 765-776
Publication  
First Author: Ding L
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice.
Volume: 118
Issue: 6
Publication  
First Author: Wu Q
Year: 2021
Journal: J Clin Invest
Title: Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.
Volume: 131
Issue: 9
Publication
First Author: Carino A
Year: 2021
Journal: FASEB J
Title: The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy.
Volume: 35
Issue: 1
Pages: e21271
Publication
First Author: De Marino S
Year: 2012
Journal: Steroids
Title: 4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity.
Volume: 77
Issue: 5
Pages: 484-95
Publication  
First Author: Li Z
Year: 2023
Journal: Int J Mol Sci
Title: FXR Maintains the Intestinal Barrier and Stemness by Regulating CYP11A1-Mediated Corticosterone Synthesis in Biliary Obstruction Diseases.
Volume: 24
Issue: 17
Publication
First Author: Milona A
Year: 2010
Journal: Hepatology
Title: Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.
Volume: 52
Issue: 4
Pages: 1341-9
Publication
First Author: Jiang T
Year: 2007
Journal: Diabetes
Title: Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
Volume: 56
Issue: 10
Pages: 2485-93
Publication
First Author: Wang XX
Year: 2017
Journal: J Biol Chem
Title: A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
Volume: 292
Issue: 29
Pages: 12018-12024
Publication
First Author: Geiger SS
Year: 2021
Journal: Nat Commun
Title: Feeding-induced resistance to acute lethal sepsis is dependent on hepatic BMAL1 and FXR signalling.
Volume: 12
Issue: 1
Pages: 2745
Publication
First Author: Tarling EJ
Year: 2015
Journal: Arterioscler Thromb Vasc Biol
Title: The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.
Volume: 35
Issue: 4
Pages: 787-95
Publication
First Author: Purushotham A
Year: 2012
Journal: Mol Cell Biol
Title: Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.
Volume: 32
Issue: 7
Pages: 1226-36
Publication
First Author: Kim T
Year: 2018
Journal: Diabetes
Title: Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21.
Volume: 67
Issue: 9
Pages: 1773-1782
Publication
First Author: Campbell C
Year: 2020
Journal: Nature
Title: Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells.
Volume: 581
Issue: 7809
Pages: 475-479
Publication  
First Author: Mathur B
Year: 2021
Journal: Sci Adv
Title: Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver.
Volume: 7
Issue: 17
Publication
First Author: Li G
Year: 2010
Journal: Mol Endocrinol
Title: Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner.
Volume: 24
Issue: 7
Pages: 1404-12
Publication
First Author: Goto T
Year: 2011
Journal: Am J Physiol Endocrinol Metab
Title: Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
Volume: 301
Issue: 5
Pages: E1022-32
Publication
First Author: Caron S
Year: 2013
Journal: Mol Cell Biol
Title: Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.
Volume: 33
Issue: 11
Pages: 2202-11
Publication
First Author: Thomas AM
Year: 2013
Journal: Pharm Res
Title: Hepatocyte nuclear factor 4 alpha and farnesoid X receptor co-regulates gene transcription in mouse livers on a genome-wide scale.
Volume: 30
Issue: 9
Pages: 2188-98
Publication
First Author: Wulfridge P
Year: 2023
Journal: PLoS Genet
Title: Precision pharmacological reversal of strain-specific diet-induced metabolic syndrome in mice informed by epigenetic and transcriptional regulation.
Volume: 19
Issue: 10
Pages: e1010997
Publication
First Author: Martin LJ
Year: 2010
Journal: Biol Reprod
Title: Nuclear receptors in Leydig cell gene expression and function.
Volume: 83
Issue: 1
Pages: 3-14
Publication
First Author: Fang S
Year: 2008
Journal: J Biol Chem
Title: The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.
Volume: 283
Issue: 50
Pages: 35086-95
Publication
First Author: Wittenburg H
Year: 2003
Journal: Gastroenterology
Title: FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice.
Volume: 125
Issue: 3
Pages: 868-81
Publication
First Author: Wang XX
Year: 2018
Journal: J Am Soc Nephrol
Title: FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Volume: 29
Issue: 1
Pages: 118-137
Publication
First Author: Jouihan H
Year: 2017
Journal: Mol Metab
Title: Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.
Volume: 6
Issue: 11
Pages: 1360-1370
Publication  
First Author: Trabelsi MS
Year: 2015
Journal: Nat Commun
Title: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
Volume: 6
Pages: 7629
Publication
First Author: Fu T
Year: 2019
Journal: Cell
Title: FXR Regulates Intestinal Cancer Stem Cell Proliferation.
Volume: 176
Issue: 5
Pages: 1098-1112.e18
Publication
First Author: Modica S
Year: 2014
Journal: J Biol Chem
Title: Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2).
Volume: 289
Issue: 41
Pages: 28421-32
Publication
First Author: Bertolini A
Year: 2019
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
Volume: 316
Issue: 3
Pages: G404-G411
Publication
First Author: Byun S
Year: 2019
Journal: J Biol Chem
Title: Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Volume: 294
Issue: 22
Pages: 8732-8744
Publication
First Author: Ikpa PT
Year: 2020
Journal: Cell Mol Gastroenterol Hepatol
Title: Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
Volume: 9
Issue: 1
Pages: 47-60
Publication
First Author: Wooton-Kee CR
Year: 2015
Journal: J Clin Invest
Title: Elevated copper impairs hepatic nuclear receptor function in Wilson's disease.
Volume: 125
Issue: 9
Pages: 3449-60
Publication  
First Author: Nason SR
Year: 2020
Journal: Endocrinology
Title: Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression.
Volume: 161
Issue: 1
Publication
First Author: Kay HY
Year: 2011
Journal: Antioxid Redox Signal
Title: Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Volume: 15
Issue: 8
Pages: 2135-46
Publication
First Author: Xu Z
Year: 2023
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Farnesoid X receptor activation inhibits pancreatic carcinogenesis.
Volume: 1869
Issue: 7
Pages: 166811
Publication
First Author: Kazgan N
Year: 2014
Journal: Gastroenterology
Title: Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1α-FXR signaling and alters systemic bile acid homeostasis.
Volume: 146
Issue: 4
Pages: 1006-16
Publication
First Author: Kim DH
Year: 2009
Journal: Mol Endocrinol
Title: ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.
Volume: 23
Issue: 10
Pages: 1556-62
Publication
First Author: Baptissart M
Year: 2016
Journal: Oncotarget
Title: Bile acid-FXRα pathways regulate male sexual maturation in mice.
Volume: 7
Issue: 15
Pages: 19468-82
Publication
First Author: Seol W
Year: 1995
Journal: Mol Endocrinol
Title: Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors.
Volume: 9
Issue: 1
Pages: 72-85
Publication
First Author: Kemper JK
Year: 2009
Journal: Cell Metab
Title: FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Volume: 10
Issue: 5
Pages: 392-404
Publication
First Author: Miao J
Year: 2009
Journal: Mol Cell Biol
Title: Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis.
Volume: 29
Issue: 23
Pages: 6170-81
Publication
First Author: Kettner NM
Year: 2016
Journal: Cancer Cell
Title: Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.
Volume: 30
Issue: 6
Pages: 909-924
Publication  
First Author: Liu Q
Year: 2016
Journal: Mol Cell Endocrinol
Title: Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression.
Volume: 436
Pages: 93-101
Publication
First Author: Kozak CA
Year: 1996
Journal: Mamm Genome
Title: Genetic mapping of gene encoding the farnesoid receptor, Fxr, to mouse Chromosome 10.
Volume: 7
Issue: 2
Pages: 164-5
Publication
First Author: Grade CVC
Year: 2017
Journal: Mol Biol Rep
Title: CREB, NF-Y and MEIS1 conserved binding sites are essential to balance Myostatin promoter/enhancer activity during early myogenesis.
Volume: 44
Issue: 5
Pages: 419-427
Publication
First Author: Chopra AR
Year: 2011
Journal: Cell Metab
Title: Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.
Volume: 13
Issue: 1
Pages: 35-43
Publication
First Author: Kyrmizi I
Year: 2006
Journal: Genes Dev
Title: Plasticity and expanding complexity of the hepatic transcription factor network during liver development.
Volume: 20
Issue: 16
Pages: 2293-305
Publication
First Author: Vergnes L
Year: 2013
Journal: Cell Metab
Title: Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.
Volume: 17
Issue: 6
Pages: 916-28
Publication
First Author: Ferrell JM
Year: 2016
Journal: J Lipid Res
Title: Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders.
Volume: 57
Issue: 7
Pages: 1144-54
Publication
First Author: Suh JM
Year: 2006
Journal: Mol Endocrinol
Title: The expression profiles of nuclear receptors in the developing and adult kidney.
Volume: 20
Issue: 12
Pages: 3412-20
Publication
First Author: Qin J
Year: 2007
Journal: Dev Dyn
Title: The expression pattern of nuclear receptors during cerebellar development.
Volume: 236
Issue: 3
Pages: 810-20
Publication
First Author: Yi J
Year: 2016
Journal: Hepatology
Title: Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Volume: 64
Issue: 5
Pages: 1757-1772
Publication
First Author: Falix FA
Year: 2014
Journal: Dev Biol
Title: Hepatic Notch2 deficiency leads to bile duct agenesis perinatally and secondary bile duct formation after weaning.
Volume: 396
Issue: 2
Pages: 201-13
Publication  
First Author: Niborski LL
Year: 2021
Journal: Dis Model Mech
Title: Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model.
Volume: 14
Issue: 5
Publication
First Author: Kaminski MM
Year: 2016
Journal: Nat Cell Biol
Title: Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors.
Volume: 18
Issue: 12
Pages: 1269-1280
Publication
First Author: Lammert F
Year: 2001
Journal: Gastroenterology
Title: Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map.
Volume: 120
Issue: 1
Pages: 221-38
Publication  
First Author: Brown AC
Year: 2005
Journal: BMC Genet
Title: Searching QTL by gene expression: analysis of diabesity.
Volume: 6
Pages: 12
Publication
First Author: Li X
Year: 2007
Journal: Physiol Genomics
Title: Deconvoluting the intestine: molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk.
Volume: 29
Issue: 3
Pages: 290-301
Publication
First Author: Choi MY
Year: 2006
Journal: Development
Title: A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development.
Volume: 133
Issue: 20
Pages: 4119-29
Publication  
First Author: Long JE
Year: 2009
Journal: Cereb Cortex
Title: Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.
Volume: 19 Suppl 1
Pages: i96-106
Publication
First Author: Thiagarajan RD
Year: 2011
Journal: PLoS One
Title: Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways.
Volume: 6
Issue: 2
Pages: e17286